Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and equivalents	$ 15,665	$ 17,957
Accounts receivable, net	258,158	155,273
Inventories	153,293	110,683
Deferred income taxes	2,503	1,813
Prepaid expenses and other current assets	7,551	5,360
Total current assets	437,170	291,086
Property and equipment, net	14,988	13,150
Capitalized software for internal use, net	35,904	13,236
Goodwill	253,426	23,148
Definite-lived intangible assets, net	233,677	44,973
Deferred debt issuance costs	5,312	921
Investment in non-consolidated entity	3,500	3,500
Other noncurrent assets	179	72
Total assets	984,156	390,086
Current liabilities:
Accounts payable	271,988	202,495
Borrowings on line of credit	21,756
Short-term debt, including current portion of long-term debt	6,000
Accrued expenses:
Contingent consideration	44,281	6,282
Compensation and benefits	6,126	2,257
Other	8,372	4,394
Total current liabilities	358,523	215,428
Long-term debt, less current portion	112,500
Contingent consideration, less current portion		5,409
Deferred income taxes	11,128	518
Other noncurrent liabilities		4
Total liabilities	$ 482,151	$ 221,359
Commitments and contingencies
Shareholders' equity:
Preferred stock (10,000,000 shares authorized; none issued and outstanding)
Common stock (no par value; 590,000,000 shares authorized; 64,253,037 and 51,457,023 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively)	$ 448,736	$ 148,901
Additional paid-in capital	21,868	9,893
Retained earnings	27,564	5,354
Total Diplomat Pharmacy shareholders' equity	498,168	164,148
Noncontrolling interests	3,837	4,579
Total shareholders' equity	502,005	168,727
Total liabilities and shareholders' equity	$ 984,156	$ 390,086